1,2,3-Triazole Linked Chalcone-Morpholine Hybrids: Synthesis, In Vitro Antibacterial Evaluation and In Silico ADMET Predictions

References

• D. Lyddiard, G.L. Jones, and B.W. Greatrex, “Keeping It Simple: Lessons from the Golden Era of Antibiotic Discovery,” FEMS Microbiology Letters 363, no. 8 (2016): fnw084.
   PubMed Web of Science ®Google Scholar
• R. Gaynes, “The Discovery of Penicillin-New Insights after More than 75 Years of Clinical Use,” Emerging Infectious Diseases 23, no. 5 (2017): 849–53. DOI:10.3201/eid2305.161556.
   Web of Science ®Google Scholar
• R.I. Aminov, “A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future,” Frontiers in Microbiology 1 (2010): 134. DOI:10.3389/fmicb.2010.00134.
   PubMed Web of Science ®Google Scholar
• C.L. Ventola, “The Antibiotic Resistance Crisis: Part 1: Causes and Threats,” P & T: A Peer-Reviewed Journal for Formulary Management 40, no. 4 (2015): 277–83.
   PubMedGoogle Scholar
• J. Davies, “Where Have All the Antibiotics Gone?,” The Canadian Journal of Infectious Diseases & Medical Microbiology 17, no. 5 (2006): 287–90. DOI:10.1155/2006/707296.
   PubMedGoogle Scholar
• S. Ashkenazi, “Beginning and Possibly the End of the Antibiotic Era,” Journal of Paediatrics and Child Health 49, no. 3 (2013): E179–82.
   PubMed Web of Science ®Google Scholar
• R.J. Fair and Y. Tor, “Antibiotics and Bacterial Resistance in the 21st Century,” Perspectives in Medicinal Chemistry 6 (2014): 25–64.
   PubMedGoogle Scholar
• F. Prestinaci, P. Pezzotti, and A. Pantosti, “Antimicrobial Resistance: A Global Multifaceted Phenomenon,” Pathogens and Global Health 109, no. 7 (2015): 309–18.
   PubMed Web of Science ®Google Scholar
• World Health Organization, “Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2021.” https://apps.who.int/iris/handle/10665/341666.
   Google Scholar
• World Health Organization, “Antibiotic Resistance,” 31 July, 2020. https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance.
   Google Scholar
• S. Donadio, S. Maffioli, P. Monciardini, M. Sosio, and D. Jabes, “Antibiotic Discovery in the Twenty-First Century: Current Trends and Future Perspectives,” The Journal of Antibiotics 63, no. 8 (2010): 423–30.
   PubMed Web of Science ®Google Scholar
• Z. Aghapour, P. Gholizadeh, K. Ganbarov, A.Z. Bialvaei, S.S. Mahmood, A. Tanomand, M. Yousefi, M. Asgharzadeh, B. Yousefi, and H.S. Kafil, “Molecular Mechanisms Related to Colistin Resistance in Enterobacteriaceae,” Infection and Drug Resistance 12 (2019): 965–75.
   PubMed Web of Science ®Google Scholar
• J.H. Moffatt, M. Harper, P. Harrison, J.D.F. Hale, E. Vinogradov, T. Seemann, R. Henry, B. Crane, F.S. Michael, A.D. Cox, et al., “Colistin Resistance in Acinetobacter baumannii is Mediated by Complete Loss of Lipopolysaccharide Production,” Antimicrobial Agents and Chemotherapy 54, no. 12 (2010): 4971–7.
   PubMed Web of Science ®Google Scholar
• M.M. Zafer, H.A. El-Mahallawy, A. Abdulhak, M.A. Amin, M.H. Al-Agamy, and H.H. Radwan, “Emergence of Colistin Resistance in Multidrug-Resistant Klebsiella pneumoniae and Escherichia coli Strains Isolated from Cancer Patients,” Annals of Clinical Microbiology and Antimicrobials 18, no. 1 (2019): 40.
   PubMed Web of Science ®Google Scholar
• L.L. Silver, “Challenges of Antibacterial Discovery,” Clinical Microbiology Reviews 24, no. 1 (2011): 71–109.
   PubMed Web of Science ®Google Scholar
• S.B. Singh and J.F. Barrett, “Empirical Antibacterial Drug Discovery-Foundation in Natural Products,” Biochemical Pharmacology 71, no. 7 (2006): 1006–15.
   PubMed Web of Science ®Google Scholar
• Review on Antimicrobial Resistance, “Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations,” 2014.
   Google Scholar
• C. Zhuang, W. Zhang, C. Sheng, W. Zhang, C. Xing, and Z. Miao, “Chalcone: A Privileged Structure in Medicinal Chemistry,” Chemical Reviews 117, no. 12 (2017): 7762–810.
   PubMed Web of Science ®Google Scholar
• D.I. Batovska and I.T. Todorova, “Trends in Utilization of the Pharmacological Potential of Chalcones,” Current Clinical Pharmacology 5, no. 1 (2010): 1–29.
   PubMedGoogle Scholar
• B. Salehi, C. Quispe, I. Chamkhi, N.E. Omari, A. Balahbib, J.S. Rad, A. Bouyahya, M. Akram, M. Iqbal, A.O. Docea, et al., “Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence,” Frontiers in Pharmacology 11 (2020): 592654.
   PubMed Web of Science ®Google Scholar
• M.N. Gomes, E.N. Muratov, M. Pereira, J.C. Peixoto, L. Rosseto, P.V.L. Cravo, C.H. Andrade, and B.J. Neves, “Chalcone Derivatives: Promising Starting Points for Drug Design,” Molecules 22, no. 8 (2017): 1210.
   PubMed Web of Science ®Google Scholar
• H.L. Qin, Z.W. Zhang, R. Lekkala, H. Alsulami, and K.P. Rakesh, “Chalcone Hybrids as Privileged Scaffolds in Antimalarial Drug Discovery: A Key Review,” European Journal of Medicinal Chemistry 193 (2020): 112215.
   PubMed Web of Science ®Google Scholar
• D.K. Mahapatra and S.K. Bharti, “Therapeutic Potential of Chalcones as Cardiovascular Agents,” Life Sciences 148 (2016): 154–72.
   PubMed Web of Science ®Google Scholar
• D. Elkhalifa, I. Al-Hashimi, A.E. Al Moustafa, and A. Khalil, “A Comprehensive Review on the Antiviral Activities of Chalcones,” Journal of Drug Targeting 29, no. 4 (2021): 403–19.
   PubMed Web of Science ®Google Scholar
• Y. Fu, D. Liu, H. Zeng, X. Ren, B. Song, D. Hu, and X. Gan, “New Chalcone Derivatives: Synthesis, Antiviral Activity and Mechanism of Action,” RSC Advances 10, no. 41 (2020): 24483–90.
   PubMed Web of Science ®Google Scholar
• B. Orlikova, D. Tasdemir, F. Golais, M. Dicato, and M. Diederich, “Dietary Chalcones with Chemopreventive and Chemotherapeutic Potential,” Genes & Nutrition 6, no. 2 (2011): 125–47.
   PubMed Web of Science ®Google Scholar
• A. Kumari and R.K. Singh, “Morpholine as Ubiquitous Pharmacophore in Medicinal Chemistry: Deep Insight into the Structure-Activity Relationship (SAR),” Bioorganic Chemistry 96 (2020): 103578.
   PubMed Web of Science ®Google Scholar
• F. Arshad, M.F. Khan, W. Akhter, M.M. Alam, L.M. Nainwal, S.K. Kaushik, M. Akhter, S. Parvez, S.M. Hasan, and M. Shaquiquzzaman, “Revealing Quinquennial Anticancer Journey of Morpholine: A SAR Based Review,” European Journal of Medicinal Chemistry 167 (2019): 324–56.
   PubMed Web of Science ®Google Scholar
• A.P. Kourounakis, D. Xanthopoulos, and A. Tzara, “Morpholine as a Privileged Structure: A Review on the Medicinal Chemistry and Pharmacological Activity of Morpholine Containing Bioactive Molecules,” Medicinal Research Reviews 40, no. 2 (2020): 709–52.
   PubMed Web of Science ®Google Scholar
• E. Polo, N.I. Arellano, L.P. Peñaloza, A.M. Bayuelo, J. Henao, A. Galdámez, and M. Gutiérrez, “Ultrasound-Assisted Synthesis of Novel Chalcone, Heterochalcone and Bis-Chalcone Derivatives and the Evaluation of Their Antioxidant Properties and as Acetylcholinesterase Inhibitors,” Bioorganic Chemistry 90 (2019): 103034.
   PubMed Web of Science ®Google Scholar
• R. Sasidharan, B.H. Eom, J.H. Heo, J.E. Park, M.A. Abdelgawad, A. Musa, N. Gambacorta, O. Nicolotti, S.L. Manju, B. Mathew, et al., “Morpholine-Based Chalcones as Dual-Acting Monoamine Oxidase-B and Acetylcholinesterase Inhibitors: Synthesis and Biochemical Investigations,” Journal of Enzyme Inhibition and Medicinal Chemistry 36, no. 1 (2021): 188–97.
   PubMed Web of Science ®Google Scholar
• K. Bozorov, J. Zhao, and H.A. Aisa, “1,2,3-Triazole-Containing Hybrids as Leads in Medicinal Chemistry: A Recent Overview,” Bioorganic & Medicinal Chemistry 27, no. 16 (2019): 3511–31.
   PubMed Web of Science ®Google Scholar
• R.R. Ruddarraju, A.C. Murugulla, R. Kotla, M. Chandra Babu Tirumalasetty, R. Wudayagiri, S. Donthabakthuni, R. Maroju, K. Baburao, and L.S. Parasa, “Design, Synthesis, Anticancer, Antimicrobial Activities and Molecular Docking Studies of Theophylline Containing Acetylenes and Theophylline Containing 1,2,3-Triazoles with Variant Nucleoside Derivatives,” European Journal of Medicinal Chemistry 123 (2016): 379–96.
   PubMed Web of Science ®Google Scholar
• E. Bonandi, M.S. Christodoulou, G. Fumagalli, D. Perdicchia, G. Rastelli, and D. Passarella, “The 1,2,3-Triazole Ring as a Bioisostere in Medicinal Chemistry,” Drug Discovery Today 22, no. 10 (2017): 1572–81.
   PubMed Web of Science ®Google Scholar
• D. Dheer, V. Singh, and R. Shankar, “Medicinal Attributes of 1,2,3-Triazoles: Current Developments,” Bioorganic Chemistry 71 (2017): 30–54.
   PubMed Web of Science ®Google Scholar
• P. Prasher, and M. Sharma, “Tailored Therapeutics Based on 1,2,3-1H-Triazoles: A Mini Review,” Medchemcomm 10, no. 8 (2019): 1302–28.
   PubMed Web of Science ®Google Scholar
• S. Basoglu, M. Yolal, A. Demirbas, H. Bektas, R. Abbasoglu, and N. Demirbas, “Synthesis of Linezolid-Like Molecules and Evaluation of Their Antimicrobial Activities,” Turkish Journal of Chemistry 36 (2012): 37–53.
   Web of Science ®Google Scholar
• D.B. Janakiramudu, D. Subba Rao, C. Srikanth, S. Madhusudhana, S. Murthy, M.N. Devamma, P.V. Chalapathi, and C. Naga Raju, “Sulfonamides and Carbamates of 3-Fluoro-4-Morpholinoaniline (Linezolid Intermediate): Synthesis, Antimicrobial Activity and Molecular Docking Study,” Research on Chemical Intermediates 44, no. 1 (2018): 469–89.
   Web of Science ®Google Scholar
• R. Gondru, S. Kanugala, S. Raj, C.G. Kumar, M. Pasupuleti, J. Banothu, and R. Bavantula, “1,2,3-Triazole-Thiazole Hybrids: Synthesis, in Vitro Antimicrobial Activity and Antibiofilm Studies,” Bioorganic & Medicinal Chemistry Letters 33 (2021): 127746.
   PubMed Web of Science ®Google Scholar
• A.W. Bauer, W.M. Kirby, J.C. Sherris, and M. Turck, “Antibiotic Susceptibility Testing by a Standardized Single Disk Method,” American Journal of Clinical Pathology 45, no. 4 (1966): 493–6.
   PubMed Web of Science ®Google Scholar
• D. Singh, V. Singh, S. Bhushan Mishra, D. Sharma, and V. Agarwal, “Evaluation of anti-Biofilm, anti-Quorum, anti-Dysenteric Potential of Designed Polyherbal Formulation: In Vitro and in Vivo Study,” Journal of Applied Biomedicine 20, no. 1 (2022): 7–14.
   PubMed Web of Science ®Google Scholar
• J.P. Hughes, S. Rees, S.B. Kalindjian, and K.L. Philpott, “Principles of Early Drug Discovery,” British Journal of Pharmacology 162, no. 6 (2011): 1239–49.
   PubMed Web of Science ®Google Scholar
• H. Waterbeemd and E. Gifford, “ADMET in Silico Modelling: Towards Prediction Paradise?,” Nature Reviews. Drug Discovery 2, no. 3 (2003): 192–204.
   PubMed Web of Science ®Google Scholar
• T. Kennedy, “Managing the Drug Discovery/Development Interface,” Drug Discovery Today 2, no. 10 (1997): 436–44.
   Web of Science ®Google Scholar
• M.J. Waring, J. Arrowsmith, A.R. Leach, P.D. Leeson, S. Mandrell, R.M. Owen, G. Pairaudeau, W.D. Pennie, S.D. Pickett, J. Wang, et al., “An Analysis of the Attrition of Drug Candidates from Four Major Pharmaceutical Companies,” Nature Reviews. Drug Discovery 14, no. 7 (2015): 475–86.
   PubMed Web of Science ®Google Scholar
• F. Curreli, D.S. Belov, Y.D. Kwon, R. Ramesh, A.M. Furimsky, K. O’Loughlin, P.C. Byrge, L.V. Iyer, J.C. Mirsalis, A.V. Kurkin, et al., “Structure-Based Lead Optimization to Improve Antiviral Potency and ADMET Properties of Phenyl-1H-Pyrrole-Carboxamide Entry Inhibitors Targeted to HIV-1 gp120,” European Journal of Medicinal Chemistry 154 (2018): 367–91.
   PubMed Web of Science ®Google Scholar
• A. Daina, O. Michielin, and V. Zoete, “SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules,” Scientific Reports 7 (2017): 42717.
   PubMed Web of Science ®Google Scholar
• D.E.V. Pires, T.L. Blundell, and D.B. Ascher, “Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures,” Journal of Medicinal Chemistry 58, no. 9 (2015): 4066–72.
   PubMed Web of Science ®Google Scholar
• C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney, “Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings,” Advanced Drug Delivery Reviews 46, no. 1–3 (2001): 3–26.
   PubMed Web of Science ®Google Scholar
• P. Ertl, B. Rohde, and P. Selzer, “Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties,” Journal of Medicinal Chemistry 43, no. 20 (2000): 3714–7.
   PubMed Web of Science ®Google Scholar